Lymph node biopsies to study HIV in different patients
Part of Infections clinical trials.
This study uses a small tissue sample from an often-accessible lymph node to learn how HIV affects the body. It may help researchers understand why some people control HIV better than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign informed consent
- Your doctor says you can safely have a surgical biopsy
- You have a lymph node in the groin area that can be felt (palpable inguinal adenopathy)
- If you have HIV, you must fit one of these groups: on stable HIV meds with undetectable viral load, an “elite controller” (not on meds) with undetectable viral load, or a “non-controller” (not on meds) with a high viral load
- Your blood counts and clotting test results must be safe for procedures and blood draws (no significant anemia or clotting problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood to help researchers run multiple projects, including comparing people who are HIV-negative with people who have HIV. It may help advance knowledge that could improve future testing or treatments.
This trial uses a special blood-filtering procedure (leukapheresis) along with blood tests to better understand how HIV affects the body. It may help researchers learn more about HIV “pathogenesis,” which means what drives disease in different people.
This study measures how much HIV is in your blood and lymph node tissue. If you qualify, you would also allow blood and other tests (including genetic and hepatitis screening), which may help researchers better understand how HIV affects the body.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
This study tests new methods to diagnose lymphoma and multicentric castleman disease, which are conditions that can affect people with HIV. It may help find these diseases earlier and more accurately.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.